Abstract Changes in immune and coagulation systems and possible viral spread through
the blood–brain barrier have been described in SARS-CoV-2 infection. In this study, we …

Chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in
people coinfected with human immunodeficiency virus (HIV). Several studies have shown …

Background: Evidence is needed on the effectiveness of wearing face masks in the community
to prevent SARS-CoV-2 transmission. Methods: Systematic review and meta-analysis to …

Background: Mounting evidence suggests SARS-CoV-2 may impact on host microbiota and
gut inflammation, infecting intestinal epithelial cells. This possible link and its implications …

Protecting Health Care Workers (HCWs) during routine care of suspected or confirmed
COVID-19 patients is of paramount importance to halt the SARS-CoV-2 (Severe Acute …

Background & Aims Despite the excellent efficacy of direct‐acting antivirals ( DAA ) reported
in clinical trials, virological failures can occur, often associated with the development of …

A significant number of COVID‐19 patients were shown to have neutralizing antibodies (NAB)
against IFN; however, NAB specificity, fluctuation over time, associations with biochemical …

Despite the SARS‐CoV‐2 pandemic not yet being under control, post‐Covid‐19 syndrome
is already a challenging topic: long‐term multiorgan sequelae, although increasingly …

Microbial translocation (MT) and intestinal damage (ID) are poorly explored in COVID-19.
Aims were to assess whether alteration of gut permeability and cell integrity characterize …

Background A pandemic outbreak of COVID‐19 has been sweeping the world since December.
It begins as a respiratory infection that, mainly in men with diabetes or renal impairment, …